{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ruxolitinib+cream&page=2", "query": { "intervention": "ruxolitinib cream", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 52, "total_pages": 6, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ruxolitinib+cream&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ruxolitinib+cream&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-07T23:47:36.208Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06673654", "title": "A Study, Comparing Ruxolitinib Topical Cream 1.5% (Taro Pharmaceuticals U.S.A, Inc.) to OPZELURA (Ruxolitinib) Cream for the Treatment of Mild-to-Moderate Atopic Dermatitis.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "Ruxolitinib Topical Cream 1.5%", "type": "DRUG" }, { "name": "OPZELURA (Ruxolitinib) Cream", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sun Pharmaceutical Industries, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 476, "start_date": "2023-08-11", "completion_date": "2024-09-23", "has_results": false, "last_update_posted_date": "2024-11-05", "last_synced_at": "2026-10-07T23:47:36.208Z", "location_count": 1, "location_summary": "Hawthorne, New York", "locations": [ { "city": "Hawthorne", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06673654" }, { "nct_id": "NCT04052425", "title": "Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Non-segmental Vitiligo" ], "interventions": [ { "name": "Ruxolitinib cream", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Incyte Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 330, "start_date": "2019-09-20", "completion_date": "2021-10-21", "has_results": true, "last_update_posted_date": "2025-08-22", "last_synced_at": "2026-10-07T23:47:36.208Z", "location_count": 29, "location_summary": "Hoover, Alabama • Scottsdale, Arizona • Hot Springs, Arkansas + 24 more", "locations": [ { "city": "Hoover", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04052425" }, { "nct_id": "NCT07049575", "title": "Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hidradenitis Suppurativa" ], "interventions": [ { "name": "Ruxolitinib Cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Incyte Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "12 Years to 75 Years" }, "enrollment_count": 24, "start_date": "2025-11-03", "completion_date": "2026-12-09", "has_results": false, "last_update_posted_date": "2026-09-15", "last_synced_at": "2026-10-07T23:47:36.208Z", "location_count": 21, "location_summary": "Phoenix, Arizona • Fountain Valley, California • Northridge, California + 17 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Northridge", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Thousand Oaks", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07049575" }, { "nct_id": "NCT05593432", "title": "A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cutaneous Lichen Planus" ], "interventions": [ { "name": "Ruxolitinib cream", "type": "DRUG" }, { "name": "Vehicle cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Incyte Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 64, "start_date": "2022-11-23", "completion_date": "2024-02-26", "has_results": true, "last_update_posted_date": "2024-10-24", "last_synced_at": "2026-10-07T23:47:36.208Z", "location_count": 22, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 19 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Skokie", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05593432" }, { "nct_id": "NCT00820950", "title": "A Study of Ruxolitinib Phosphate Cream When Applied to Patients With Plaque Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Psoriasis" ], "interventions": [ { "name": "Ruxolitinib phosphate cream", "type": "DRUG" }, { "name": "Dovonex® calcipotriene 0.005%", "type": "DRUG" }, { "name": "Diprolene® AF betamethasone dipropionate 0.05% cream.", "type": "DRUG" }, { "name": "Placebo cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Incyte Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 29, "start_date": "2007-05-31", "completion_date": "2009-04-30", "has_results": true, "last_update_posted_date": "2022-02-08", "last_synced_at": "2026-10-07T23:47:36.208Z", "location_count": 6, "location_summary": "Vallejo, California • Boston, Massachusetts • Rochester, New York + 3 more", "locations": [ { "city": "Vallejo", "state": "California" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Rochester", "state": "New York" }, { "city": "Stony Brook", "state": "New York" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT00820950" }, { "nct_id": "NCT03011892", "title": "A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "Ruxolitinib 0.15% Cream QD", "type": "DRUG" }, { "name": "Ruxolitinib 0.5% Cream QD", "type": "DRUG" }, { "name": "Ruxolitinib 1.5% Cream QD", "type": "DRUG" }, { "name": "Ruxolitinib 1.5% Cream BID", "type": "DRUG" }, { "name": "Triamcinolone 0.1% Cream BID", "type": "DRUG" }, { "name": "Vehicle Cream BID", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Incyte Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 307, "start_date": "2017-01-09", "completion_date": "2018-03-12", "has_results": true, "last_update_posted_date": "2021-04-09", "last_synced_at": "2026-10-07T23:47:36.208Z", "location_count": 35, "location_summary": "Birmingham, Alabama • Bryant, Arkansas • Encino, California + 28 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Bryant", "state": "Arkansas" }, { "city": "Encino", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Oceanside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03011892" }, { "nct_id": "NCT03954236", "title": "Study of the Safety and Efficacy of Ruxolitinib Cream for Non-Sclerotic Chronic Cutaneous Graft-Versus-Host Disease", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Non-sclerotic Cutaneous Chronic Graft-versus-host Disease" ], "interventions": [ { "name": "topical ruxolitinib 1.5% cream", "type": "DRUG" }, { "name": "Topical vehicle/moisturizer cream", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 24, "start_date": "2019-05-14", "completion_date": "2027-02-06", "has_results": true, "last_update_posted_date": "2026-07-10", "last_synced_at": "2026-10-07T23:47:36.208Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03954236" }, { "nct_id": "NCT04530344", "title": "Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Vitiligo" ], "interventions": [ { "name": "ruxolitinib", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Incyte Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 458, "start_date": "2020-09-24", "completion_date": "2022-11-14", "has_results": true, "last_update_posted_date": "2025-08-14", "last_synced_at": "2026-10-07T23:47:36.208Z", "location_count": 44, "location_summary": "Hoover, Alabama • Gilbert, Arizona • Fountain Valley, California + 36 more", "locations": [ { "city": "Hoover", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Fremont", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04530344" }, { "nct_id": "NCT05755438", "title": "A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Prurigo" ], "interventions": [ { "name": "Ruxolitinib Cream", "type": "DRUG" }, { "name": "Vehicle Cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Incyte Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 204, "start_date": "2023-03-10", "completion_date": "2025-08-13", "has_results": true, "last_update_posted_date": "2026-08-12", "last_synced_at": "2026-10-07T23:47:36.208Z", "location_count": 18, "location_summary": "Phoenix, Arizona • Fort Smith, Arkansas • Fountain Valley, California + 15 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Fort Smith", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Rockville", "state": "Maryland" }, { "city": "Clarkston", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT05755438" }, { "nct_id": "NCT04492618", "title": "Ruxolitinib Cream in the Treatment of Cutaneous Necrobiosis Lipoidica", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Necrobiosis Lipoidica" ], "interventions": [ { "name": "Ruxolitinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Aaron R. Mangold", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 12, "start_date": "2020-09-29", "completion_date": "2022-03-16", "has_results": true, "last_update_posted_date": "2023-02-08", "last_synced_at": "2026-10-07T23:47:36.208Z", "location_count": 1, "location_summary": "Scottsdale, Arizona", "locations": [ { "city": "Scottsdale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT04492618" } ] }